Plain-English translation of NCT07720765 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →This study uses a non-invasive eye-imaging technology called Optical Coherence Tomography (OCT) to see if changes in the retina (the light-sensing tissue at the back of your eye) can help doctors better understand and track neurological diseases. The researchers want to learn whether OCT can become a simple, affordable tool to help diagnose and monitor conditions like Multiple Sclerosis, Alzheimer's disease, Parkinson's disease, and migraines.
Many serious neurological diseases affect not just the brain but also the eyes and optic nerve. This imaging technique is already safe and widely available, so if it can reliably detect these diseases or track how they're progressing, it could become a valuable tool for doctors—without needing expensive or invasive tests.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have an eye scan using the OCT machine at your first visit, then return for follow-up scans at 6 months, 12 months, 18 months, and/or 24 months. During these visits, you may also have standard neurological tests or assessments (like memory tests or movement evaluations, depending on your condition). The eye scanning itself is quick, non-invasive, and painless—similar to taking a photograph of the back of your eye.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
Italy